Xeris Biopharma Reports Third Quarter 2021 Financial Results and Other Highlights
Go back to Xeris Biopharma Reports Third Quarter 2021 Financial Results and Other Highlights| (NASDAQ: XERS) | Delayed: 6.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.95 | 52 Week High | $ | |||
| Open | $6.95 | 52 Week Low | $ | |||
| Day High | $6.95 | P/E | N/A | |||
| Day Low | $6.95 | EPS | $ | |||
| Volume | 2,999 | |||||

